The companies will jointly offer pathology and molecular testing services to PPD's pharmaceutical and biotechnology customers.
The companies will pair Freenome's AI genomics platform with various Qiagen molecular analysis platforms and co-market the technologies to pharmaceutical companies.
The New York Genome Center spinout has focused on developing imputation algorithms to enable low-coverage whole-genome sequencing for as low as $50 per sample.
Consent — and the right to withdraw it — underlies the EU's newly effective General Data Protection Regulation for researchers in Europe and beyond.
Centogene will help Aldeyra identify patients with Sjögren-Larsson Syndrome, a rare genetic disease for which Aldeyra is developing a treatment.
In December, the organization committed $1.2 million to support the creation of an ME/CFS research center at Stanford University.
The partners will develop and implement bioinformatics tools, pipelines, and techniques to improve molecular profiling for research and clinical oncology.
The company will use the funds to further develop its cloud-based alternative splicing analysis platform for drug discovery.
The All of Us Participant Technology Systems Center offers web and mobile apps to aggregate data and engage patients who join the All of Us cohort program.
The startup plans to harness single-cell genomics and computational analysis to discover therapies for autoimmune disease and cancer.
Malaysia-based ScienceVision has agreed to commercialize and distribute the PierianDx Clinical Genomics Workspace platform in Southeast Asian countries.
George Church's Nebula is teaming with Hong Kong startup Longenesis to create a secure platform for individuals and biobanks to sell access to their genomes.
Illumina said the acquisition will help enable a standardized process for sequencing and analysis and speed up the time it take to get a result.
Though it's still struggling with data integration, Detroit's Henry Ford Health System is standardizing workflows and beginning to measure outcomes.
MIT and Stanford computer scientists developed a technique for secure, massively scalable genomic analysis that they hope will unleash greater data sharing.
BC Platforms will incorporate Sentieon's next-generation sequencing data-processing software into its integrated genomics and clinical data products.
The company said 677 of its GPS Cancer commercial tests were ordered in Q1 2018, up from 606 in Q4 2017.
Luna DNA, which offers a cryptocurrency to reward people for sharing biological and medical data with researchers, has raised $4 million to date.
With the Series B funding, Sytenkabio will consolidate its headquarters in Seoul, validate its technology, and look to expand into international markets.
As part of a new partnership, Partek Flow NGS analysis software will help researchers access single-cell RNA sequences without the need for bioinformatics expertise.
A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.
Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.
A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.
In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more